Shopping Cart
Remove All
Your shopping cart is currently empty
Figitumumab (Synonyms: CP-751871)
Catalog No. T76746 Copy Product Info
🥰Excellent
Figitumumab (CP-751871) is a highly potent, fully human monoclonal antibody of the IgG2 isotype that specifically targets the insulin-like growth factor 1 receptor (IGF1R). it functions by competitively inhibiting the binding of IGF1 to its receptor with a IC50 of 1.8 nM. Figitumumab can be used in studies about advanced squamous cell carcinoma of the lung.
Figitumumab
Copy Product Info🥰Excellent
Catalog No. T76746
Synonyms CP-751871
Figitumumab (CP-751871) is a highly potent, fully human monoclonal antibody of the IgG2 isotype that specifically targets the insulin-like growth factor 1 receptor (IGF1R). it functions by competitively inhibiting the binding of IGF1 to its receptor with a IC50 of 1.8 nM. Figitumumab can be used in studies about advanced squamous cell carcinoma of the lung.
Figitumumab
Cas No. 943453-46-1
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $747 | - | In Stock | |
| 10 mg | $1,200 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:≥95% (SDS-PAGE); 99.1% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Figitumumab (CP-751871) is a highly potent, fully human monoclonal antibody of the IgG2 isotype that specifically targets the insulin-like growth factor 1 receptor (IGF1R). it functions by competitively inhibiting the binding of IGF1 to its receptor with a IC50 of 1.8 nM. Figitumumab can be used in studies about advanced squamous cell carcinoma of the lung. |
| In vitro | Figitumumab (CP-751871) (152 pM-10 μM, 3 days) can inhibit cancer cell proliferation. [1] |
| Synonyms | CP-751871 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IGF1-R/IGFR1/CD221 |
| Molecular Weight | ~150 kDa |
| Cas No. | 943453-46-1 |
| Isotype | Human IgG2 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Figitumumab | purchase Figitumumab | Figitumumab cost | order Figitumumab | Figitumumab in vitro | Figitumumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.